Ignite Creation Date:
2024-05-06 @ 3:08 PM
Last Modification Date:
2024-10-26 @ 1:43 PM
Study NCT ID:
NCT04530656
Status:
COMPLETED
Last Update Posted:
2022-06-01
First Post:
2020-08-27
Brief Title:
Phase I Trial of a Recombinant SARS-CoV-2 Vaccine Sf9 Cell
Sponsor:
Jiangsu Province Centers for Disease Control and Prevention
Organization:
Jiangsu Province Centers for Disease Control and Prevention